Compare BNTC & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNTC | LFMD |
|---|---|---|
| Founded | 1995 | 1994 |
| Country | United States | United States |
| Employees | 24 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 396.3M | 218.1M |
| IPO Year | 2020 | 2012 |
| Metric | BNTC | LFMD |
|---|---|---|
| Price | $10.99 | $3.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $27.67 | $9.14 |
| AVG Volume (30 Days) | 118.5K | ★ 714.1K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 6.67 | ★ 141.67 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $12,468,578.00 |
| Revenue This Year | N/A | $17.52 |
| Revenue Next Year | N/A | $18.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 49.79 |
| 52 Week Low | $9.85 | $2.60 |
| 52 Week High | $16.76 | $7.32 |
| Indicator | BNTC | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 36.33 | 49.12 |
| Support Level | $10.04 | $2.96 |
| Resistance Level | $14.14 | $3.41 |
| Average True Range (ATR) | 0.65 | 0.17 |
| MACD | -0.17 | 0.05 |
| Stochastic Oscillator | 9.25 | 61.34 |
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.